Effects of a Novel TRH Analog, JTP-2942, on Cholinergic and Monoaminergic Neurons in the Brain

  • Katsuo Toide
  • Masahiko Shinoda
  • Fumihiko Yonemori
  • Kunio Iwata
Part of the Advances in Behavioral Biology book series (ABBI, volume 44)


Thyrotropin-releasing hormone (TRH) is a hypothalamic hormone that releases thyrotropin and prolactin from the anterior pituitary gland. TRH and its receptor are widely distributed throughout the brain, including the amygdala, medulla, cerebral cortex, septal region, and hippocampus,1–4 suggesting that TRH may play an important role as a neurotransmitter as well as a neuromodulator regulating the functions of cholinergic5–7 and monoaminergic neurons.8,9 At present, several TRH analogues designed to reduce the hormonal actions and to increase the potency and duration of the central actions of TRH are under clinical investigation for the treatment of spinal cord injury, traumatic brain injury, and Alzheimer’s disease.10,11 A novel TRH analogue, Nα-[(1S, 2R)-2-methyl-4-oxocyclopentanecarbonyl]-L-histidyl-L-prolineamide (JTP-2942), with a cyclopentanone structure substituted for the pyroglutamyl moiety of TRH, has recently been demonstrated to have an increased therapeutic potency compared with the parent compound.12 JTP-2942 has been shown to cause reversal of experimental amnesia13 and to enhance both learning and memory in rodents in a Morris water maze study. The present study was performed to clarify the effects of JTP-2942 on cholinergic and monoaminergic neurons.


Thyrotropin Release Hormone Corpus Striatum Medial Septum Choline Level Thyrotropin Release Hormone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Boler, F.M. Enzmann, K. Folkers, C. Bowers, and A.V. Schalley, The identity of chemical and hormonal properties of thyrotropin-releasing hormone and pyroglutamyl-histidyl-prolineamide, Biochem. Biophys. Res. Commun. 37: 705 (1969).PubMedCrossRefGoogle Scholar
  2. 2.
    M.J. Brownstein, M. Palkovits, J.M. Saavedra, R.M. Bassin, and R.D. Utiger, Thyrotropin-releasing hormone in specific nuclei of rat brain, Science 185: 267 (1974).PubMedCrossRefGoogle Scholar
  3. 3.
    J.E. Morley Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions, Life Sci. 25: 1539 (1979).CrossRefGoogle Scholar
  4. 4.
    N.S. Pilotte, N.A. Sharif, and D.R. Burt, Characterization and autoradiographic localization of TRH receptors in sections of rat brain, Brain Res. 293:372 (1984).Google Scholar
  5. 5.
    A. Horita, M.A. Carino, and H. Lai, Pharmacology of thyrotropin-releasing hormone, Ann. Rev. Pharmacol. Toxicol. 26: 311 (1986).CrossRefGoogle Scholar
  6. 6.
    M.G. Giovannini, F. Casamenti, A. Nistri, F. Paoli, and G. Pepeu, Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis, Br. J. Pharmacol. 102: 363 (1991).PubMedCrossRefGoogle Scholar
  7. 7.
    K. Toide, M. Shinoda, M. Takase, K. Iwata, and H. Yoshida, Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus 233: 21 (1993).Google Scholar
  8. 8.
    S. Narumi, Y. Nagai, M. Miyamoto, and Y. Nagawa, Thyrotropin-releasing hormone (TRH) and its analog (DN-1417); interaction with pentobarbital in choline uptake and acetylcholine synthesis of rat brain slices, Life Sci. 32: 1637 (1983).PubMedCrossRefGoogle Scholar
  9. 9.
    M. Shinoda, K. Toide, and K. Iwata, Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on dopaminergic neurons of rat brain, Jpn. J. Pharmacol. 24 58: Suppl. 371 (1992).Google Scholar
  10. 10.
    E.C. Griffiths, Clinical applications of thyrotropin releasing hormone, Clinical Sci. 73: 449 (1987).Google Scholar
  11. 11.
    A.I. Faden, and S. Salzman, Pharmacological strategies in CNS trauma, Trends Pharmacol. Sci. 13: 29 (1992).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Haruta, K. Sakuma, A. Yasuda, K. Hara, A. Saito, F. Yonemori, M. Matsushita, N. Furukawa, A. Uemura, K. Iwata, and I. Uchida, The synthesis and phannacological activities of TRH analogues, (Abstr) 12th Symposium Med. Chem. Soc. (Japan) 52: (1991).Google Scholar
  13. 13.
    A. Uemura, F. Yonemori, N. Furukawa, K. Toide, and K. Iwata, Effect of novel TRH analogue, JTP-2942, on various amnesia models in rodents, Jpn. J. Pharmacol. 61:Supp1. 187 (1993).Google Scholar
  14. 14.
    G. Paxinos, and C. Watson, The rat brain in stereotaxic coordinates, Academic Press, New York. 15. G. Damsma, B.H.C. Westerink, A. Imperato, H. Rollema, J.B. De Vries, and A.S. Horn, Automated brain dialysis of acetylcholine in freely moving rats: detection of basal acetylcholine, Life Sci. 43: 873 (1987).CrossRefGoogle Scholar
  15. 16.
    G. Damsma, B.H.C.Westerink, P. De Boer, J.B. De Vries, and A.S. Horn, Basal acetylcholine release in freely moving rats detected by on-line transstriatal dialysis: pharmacological aspects, Life Sci. 43: 1161 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Katsuo Toide
    • 1
  • Masahiko Shinoda
    • 1
  • Fumihiko Yonemori
    • 1
  • Kunio Iwata
    • 1
  1. 1.Central Pharmaceutical Research InstituteJapan Tobacco Inc.Takatsuki, Osaka 569Japan

Personalised recommendations